XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)
3 Months Ended
Mar. 31, 2022
JP Kush and Associates Inc [Member]  
Business Acquisition [Line Items]  
SCHEDULE OF ALLOCATION OF PURCHASE PRICE

The allocation of the purchase price in connection with the Kush Acquisition was calculated as follows:

 

Description  Fair Value  

Weighted Average

Useful Life

(Years)

Accounts receivable  $291,414    
Trade name and trademarks   685,400   5
Customer relationships   551,000   10
Non-competition agreements   827,800   5
Goodwill   1,288,552   Indefinite
Purchase consideration allocated  $3,644,166    
SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION

SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION

     March 31, 
   2021 
Revenue  $2,695,843 
Net Income (Loss)  $(450,868)
Earnings (Loss) per common share, basic  $(0.90)
Earnings (Loss) per common share, diluted  $(0.90)

Medigap Healthcare Insurance Company [Member]  
Business Acquisition [Line Items]  
SCHEDULE OF ALLOCATION OF PURCHASE PRICE

The preliminary allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:

 

Description  Fair Value   Weighted Average Useful Life (Years)
Property, plant and equipment  $20,666   5
Right-of-use asset   317,787    
Trade names   340,000   15
Customer relationships   4,550,000   12
Technology   67,000   3
Backlog   210,000   1
Chargeback reserve   (1,484,473)   
Lease liability   (317,787)   
Goodwill   19,199,008   Indefinite
   $22,902,201    
SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION

     March 31,     March 31, 
   2022   2021 
Revenue  $4,659,451   $3,602,106 
Net Income (Loss)  $9,355,584   $(566,903)
Earnings (Loss) per common share, basic  $7.65   $1.2)
Earnings (Loss) per common share, diluted  $1.80   $1.2)